Condensed Consolidated Interim Financial Statements as of March 31, 2018

Bayer Group
Consolidated Statements of Changes in Equity

 

 

Capital stock

 

Capital reserves

 

Other reserves

 

Equity attributable to Bayer AG stockholders

 

Equity attributable to non-controlling interest

 

Equity

 

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

Dec. 31, 2016

 

2,117

 

9,658

 

18,558

 

30,333

 

1,564

 

31,897

Equity transactions with owners

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase / decrease

 

 

 

 

 

 

 

 

 

 

 

 

Dividend payments

 

 

 

 

 

 

 

 

 

 

 

 

Other changes

 

 

 

 

 

995

 

995

 

465

 

1,460

Total comprehensive income

 

 

 

 

 

2,289

 

2,289

 

211

 

2,500

March 31, 2017

 

2,117

 

9,658

 

21,842

 

33,617

 

2,240

 

35,857

Dec. 31, 2017

 

2,117

 

9,658

 

25,026

 

36,801

 

60

 

36,861

Adjustment on adoption of IFRS 9 (net of tax)

 

 

 

 

 

(60)

 

(60)

 

 

 

(60)

Adjustment on adoption of IFRS 15 (net of tax)

 

 

 

 

 

86

 

86

 

 

 

86

Equity transactions with owners

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase / decrease

 

 

 

 

 

 

 

 

 

 

 

 

Dividend payments

 

 

 

 

 

 

 

 

 

 

 

 

Other changes

 

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive income

 

 

 

 

 

1,501

 

1,501

 

(4)

 

1,497

March 31, 2018

 

2,117

 

9,658

 

26,553

 

38,328

 

56

 

38,384

Compare to Last Year